- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT01114269
사전 결정 코호트 연구
사전 결정: 생물학적 마커 및 MRI SCD 코호트 연구
This is a prospective, multi-center cohort study of patients with a history of coronary artery disease (CAD) and documentation of either a prior myocardial infarction (MI) or mild to moderate left ventricular dysfunction (LVEF 35-50%). The primary objective of this study is to determine whether biologic markers and ECGs can be utilized to advance SCD risk prediction in patients with CHD and LVEF>30-35%. The overarching goal of the study is to identify a series of markers that alone or in combination specifically predict risk of arrhythmic death as compared to other causes of mortality among this at risk population of coronary heart disease (CHD) patients with preserved left ventricular ejection fraction (LVEF> 30-35%). If biologic or ECG markers are identified that can specifically predict risk of ventricular arrhythmias, then these markers may serve as relatively inexpensive methods to identify those at risk. The public health impact of identifying markers could be quite substantial, leading to more efficient utilization of ICDs and advances in our understanding of mechanisms underlying SCD.
연구 개요
상세 설명
The PRE-DETERMINE Study is a prospective, multi-center study of patients with a history of coronary artery disease (CAD) and documentation of either a prior myocardial infarction (MI) or mild to moderate left ventricular dysfunction (LVEF 35-50%). Patients were enrolled at 135 sites where information on baseline demographics, clinical characteristics, pertinent past medical history, lifestyle habits, cardiac test results, and medications were collected via electronic data capture. Electrocardiograms along with a blood sample was also collected at baseline, sent to central laboratories, and stored for future analyses. Contrast-enhanced magnetic resonance imaging (CE-MRI) scans were collected on a subset of patients and analyzed. Enrollment closed in November 2013 and patients are now being followed centrally by the Clinical Coordinating Center via mail/phone to document interim non-fatal arrhythmic events and cause-specific mortality. Questionnaires that inquire about intervening ICD implantations, ICD therapies, cardiac arrest, and other pertinent cardiovascular endpoints are mailed to participants every six months, and follow-up telephone calls are made to non-responders. Study endpoints are being confirmed through review of medical records, interviews with next-of-kin, and autopsy reports, if available.
연구 유형
등록 (실제)
연락처 및 위치
연구 장소
-
-
Alaska
-
Anchorage, Alaska, 미국, 99508
- Alaska Heart Institute
-
-
Arizona
-
Glendale, Arizona, 미국, 85306
- Phoenix Heart, PLLC
-
Phoenix, Arizona, 미국, 85032
- Cardiovascular Consultants
-
-
California
-
Banning, California, 미국, 92220
- Beaver Medical Group/Clinical Care Research
-
-
Colorado
-
Colorado Springs, Colorado, 미국, 80909
- Memorial Health System
-
Denver, Colorado, 미국, 80204
- Colorado Heart and Vascular
-
-
Florida
-
Brandon, Florida, 미국, 33511
- Bay Area Cardiology Associates, P.A.
-
Gainesville, Florida, 미국, 32610
- University of Florida - Gainsville
-
Miami, Florida, 미국, 33135
- Reliable Clinical Research
-
Miami Beach, Florida, 미국, 33140
- Mount Sinai Medical Center
-
Orlando, Florida, 미국, 32804
- Florida Hospital
-
Orlando, Florida, 미국, 32806
- Orlando Regional Medical Center
-
Palm Beach Gardens, Florida, 미국, 33410
- Palm Beach Gardens Research Center
-
Sarasota, Florida, 미국, 34233
- Velella Research
-
Tallahassee, Florida, 미국, 32308
- Tallahassee Research Institute, Inc.
-
West Palm Beach, Florida, 미국, 33401
- Cardiology Associates of Palm Beach - West Palm Beach
-
-
Georgia
-
Covington, Georgia, 미국, 30014
- Georgia Heart Specialist
-
Gainesville, Georgia, 미국, 30501
- Northeast Georgia Heart Center, P.C.
-
-
Illinois
-
Chicago, Illinois, 미국, 60637
- University of Chicago
-
Chicago, Illinois, 미국, 60643
- Advocate Medical Group
-
Chicago, Illinois, 미국, 60657
- Advocate Medical Group - Heart and Vascular of IL
-
Melrose Park, Illinois, 미국, 60160
- Consultants in Cardiovascular Medicine
-
-
Indiana
-
Anderson, Indiana, 미국, 46011
- Community Heart and Vascular
-
-
Iowa
-
West Des Moines, Iowa, 미국, 50266
- Iowa Heart Center
-
-
Kansas
-
Kansas City, Kansas, 미국, 66160
- The University of Kansas
-
-
Kentucky
-
Lexington, Kentucky, 미국, 40503
- Baptist Health Lexington
-
-
Louisiana
-
Houma, Louisiana, 미국, 70363
- Leonard J. Chabert Medical Center
-
-
Maine
-
Auburn, Maine, 미국, 04210
- Maine Research Associates
-
Lewiston, Maine, 미국, 04240
- Maine Research Associates - Lewiston
-
-
Maryland
-
Baltimore, Maryland, 미국, 21201
- University of Maryland Medical Center
-
-
Massachusetts
-
Ayer, Massachusetts, 미국, 01432
- Primary Care Cardiology Research
-
Boston, Massachusetts, 미국, 02115
- Brigham and Women's Hospital
-
Fall River, Massachusetts, 미국, 02720
- NECCR Internal Medicine and Cardiology Associates, LLC
-
North Dartmouth, Massachusetts, 미국, 02747
- Hawthorn Medical Associates
-
Springfield, Massachusetts, 미국, 01199
- Baystate Cardiology
-
-
Michigan
-
Ann Arbor, Michigan, 미국, 48109
- University of Michigan Medical Center
-
Dearborn, Michigan, 미국, 48124
- Oakwood Hospital & Medical Center
-
Mount Clemens, Michigan, 미국, 48043
- McLaren Medical Center - Macomb
-
Ypsilanti, Michigan, 미국, 48197
- Michigan Heart
-
-
Minnesota
-
Minneapolis, Minnesota, 미국, 55417
- Minneapolis VA Medical Center
-
-
Missouri
-
Columbia, Missouri, 미국, 65201
- University of Missouri Health Care
-
-
Montana
-
Kalispell, Montana, 미국, 59901
- Glacier View Cardiology
-
-
Nebraska
-
Omaha, Nebraska, 미국, 68131
- The Cardiac Center of Creighton University
-
-
New Jersey
-
Bridgewater, New Jersey, 미국, 08807
- Advanced Heartcare, LLC
-
Paterson, New Jersey, 미국, 07503
- St. Joseph Regional Medical Center
-
-
New Mexico
-
Albuquerque, New Mexico, 미국, 87108
- New Mexico VA Healthcare Systems
-
-
New York
-
Albany, New York, 미국, 12205
- Albany Associates Cardiology
-
Brooklyn, New York, 미국, 11219
- Maimonides Medical Center
-
Buffalo, New York, 미국, 14203
- Buffalo General Hospital/Kaleida Health
-
Jamaica, New York, 미국, 11418
- Jamaica Hospital Medical Center
-
Kingston, New York, 미국, 12401
- Mid-Valley Cardiology
-
Mineola, New York, 미국, 11501
- Winthrop-University Hospital
-
New York, New York, 미국, 10001
- Gotham Cardiovascular
-
New York, New York, 미국, 10032
- Columbia University Health Center
-
Stony Brook, New York, 미국, 11794
- Stony Brook University Medical Center
-
Utica, New York, 미국, 13501
- St. Elizabeth Medical Center - Hotvedt
-
-
North Carolina
-
Asheville, North Carolina, 미국, 28801
- Asheville Cardiology Associates
-
Elizabeth City, North Carolina, 미국, 27909
- Eastern Carolina Cardiovascular
-
Lenoir, North Carolina, 미국, 28645
- Northstate Clinical Research
-
Pinehurst, North Carolina, 미국, 28374
- Pinehurst Medical Clinic, Inc.
-
Sanford, North Carolina, 미국, 27330
- Sanford Cardiology
-
Winston-Salem, North Carolina, 미국, 27157
- Wake Forest
-
-
Ohio
-
Akron, Ohio, 미국, 44304
- Northeast Ohio Cardiovascular Specialists
-
Cincinnati, Ohio, 미국, 45267
- University of Cincinnati
-
Cleveland, Ohio, 미국, 44109
- MetroHealth Medical Center
-
Elyria, Ohio, 미국, 44035
- North Ohio Research, Ltd.
-
Fairfield, Ohio, 미국, 45014
- Mercy Medical Associates
-
Toledo, Ohio, 미국, 43615
- Northwest Ohio Cardiology Consultants/The Toledo Hospital
-
-
Oklahoma
-
Oklahoma City, Oklahoma, 미국, 73120
- Oklahoma Foundation for Cardiovascular Research
-
Oklahoma City, Oklahoma, 미국, 73104
- Oklahoma City VA Medical Center Veterans Research and Education Foundation
-
-
Pennsylvania
-
Abington, Pennsylvania, 미국, 19001
- Abington Memorial Hospital
-
Bethlehem, Pennsylvania, 미국, 18018
- St. Luke's Bethlehem
-
Doylestown, Pennsylvania, 미국, 18901
- Doylestown Cardiology Associates
-
Pittsburgh, Pennsylvania, 미국, 15212
- Allegheny General Hospital
-
Pittsburgh, Pennsylvania, 미국, 15213
- University of Pittsburgh Medical Center
-
-
South Carolina
-
Anderson, South Carolina, 미국, 29621
- AnMed Health
-
Charleston, South Carolina, 미국, 29425
- VA Medical Center - Charleston
-
Rock Hill, South Carolina, 미국, 29732
- Carolina Cardiology Associates
-
-
South Dakota
-
Rapid City, South Dakota, 미국, 57701
- Black Hills Cardiovascular Research
-
-
Tennessee
-
Knoxville, Tennessee, 미국, 37917
- Cardiovasular Research of Knoxville
-
Memphis, Tennessee, 미국, 38104
- Memphis VA Medical Center
-
-
Texas
-
Houston, Texas, 미국, 77030
- St. Luke's Episcopal Hospital
-
Houston, Texas, 미국, 77074
- Non-Invasive Cardiovascular PA
-
Waco, Texas, 미국, 76712
- Providence Health Center
-
-
Utah
-
Murray, Utah, 미국, 84157
- Intermountain Medical Center
-
-
Virginia
-
Virginia Beach, Virginia, 미국, 23454
- Cardiovascular Associates Virginia Beach
-
-
-
-
Alberta
-
Edmonton, Alberta, 캐나다, T6G 2B7
- University of Alberta
-
-
British Columbia
-
Vancouver, British Columbia, 캐나다, V5Z 1M9
- Vancouver General Hospital
-
-
Ontario
-
Mississauga, Ontario, 캐나다, L5B 2P7
- Mississauga Clinical Research Centre
-
-
-
-
-
Rio Piedras, 푸에르토 리코, 00924
- Transcatheter Medical, Inc. Centro Cardiovascular de Caguas y del Caribe
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
샘플링 방법
연구 인구
Participants have been recruited throughout multicenter sites participating in the PRE-DETERMINE Cohort Study. Patients with a history of coronary artery disease and documentation of either a prior myocardial infarction (MI) or mild to moderate left ventricular dysfunction (LVEF 35-50%) have been enrolled. The clinical study staff at each site, which was either a research nurse, fellow, or physician approached eligible patients to discuss their potential participation.
설명
Inclusion Criteria:
-
Evidence of Coronary Artery Disease (CAD) a or documented prior Myocardial Infarction.
-
LVEF >35% by any current standard evaluation technique (e.g.,) echocardiogram, MUGA, angiography). 2.1. Patients who have an LVEF between 30-35% and NYHA Class I heart failure who do not have history of ventricular tachyarrhythmias,or inducible ventricular tachycardia during electrophysiological (EP) testing can be enrolled.
-
If documented prior MI is not present, evidence of mild-moderate systolic Left Ventricular Dysfunction with an EF >35- ≤50% as measured by any current standard screening technique (e.g.,echocardiogram, MUGA, angiography) must be present.
-
Patients aged 18 years or above
-
CAD will be defined as evidence of one of the following two (2) criteria:
- Significant stenosis of a major epicardial vessel (>50% proximal or 70% distal) by coronary angiography
- Prior revascularization (percutaneous coronary intervention or coronary artery bypass surgery)
-
MI can be documented in the following ways:
-
From the MI hospitalization: Detection of a rise and fall of cardiac biomarkers > 99th percentile of lab (e.g., CPK elevation or Troponin at least > two times the upper limit of normal) together with myocardial ischemia with at least one of the following:
- Symptoms of Ischemia
- ECG changes indicative of new ischemia (new ST-T changes or new LBBB)
- Development of pathological Q waves
- Imaging evidence of new loss of viable myocardium or new regional wall motion abnormality
-
If no report from the MI hospitalization is available, prior MI can be met by either of the following:
- Development of pathological Q waves
- Imaging evidence of a region of loss of viable myocardium that is thinned and fails to contract, in the absence of a non-ischaemic cause
-
-
Exclusion Criteria:
- History of cardiac arrest or spontaneous or inducible sustained VT (15 beats or more at a rate of 120 BPM or greater - the occurrence of cardiac arrest or spontaneous VT in the setting of an acute MI is not considered an exclusion).
- Unexplained syncope
- Current or planned implantable cardiac defibrillator (ICD)
- Any condition other than cardiac disease that, in the investigator's judgment, would seriously limit life expectancy (poor survival)
- Metastatic cancer
- Marked valvular heart disease requiring surgical intervention
- Current or planned cardiac, renal or liver transplant
- Current alcohol or drug abuse
- Unwilling or unable to provide informed consent
- LVEF <35% with Class II-IV CHF or LVEF <30%
- Participation in a clinical trial where the active treatment arm is testing an agent and/or intervention with known antiarrhythmic properties
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 관찰 모델: COHORT
- 시간 관점: PROSPECTIVE
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Sudden and/or arrhythmic cardiac death or resuscitated ventricular fibrillation.
기간: Median follow-up estimated to be 10.7 years
|
A definite sudden cardiac death (SCD) is defined as a death or fatal cardiac arrest occurring within 1 hour of symptom onset or the presence of autopsy consistent with SCD (e.g. acute coronary thrombosis). Probable SCD is defined as an unwitnessed death or death during sleep where the participant was observed to be symptom-free within the preceding 24 hours. Arrhythmic death is defined as the abrupt spontaneous collapse of circulation without antecedent circulatory or neurologic impairment. Deaths classified as non-arrhythmic are not included in the primary endpoint regardless of timing. Resuscitated ventricular fibrillation is defined as out-of-hospital cardiac arrests with documented VF and/or use of external electrical defibrillation for resuscitation. |
Median follow-up estimated to be 10.7 years
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
ICD 이식
기간: 평균 추적 기간은 10.7년으로 추정됨
|
평균 추적 기간은 10.7년으로 추정됨
|
|
|
총 심장 사망률
기간: 평균 추적 기간은 10.7년으로 추정됨
|
평균 추적 기간은 10.7년으로 추정됨
|
|
|
총 사망률
기간: 평균 추적 기간은 10.7년으로 추정됨
|
평균 추적 기간은 10.7년으로 추정됨
|
|
|
ICD Shock
기간: Median follow-up estimated to be 10.7 years
|
ICD therapies for ventricular arrhythmias over 200 BPMs will be added to the endpoint. |
Median follow-up estimated to be 10.7 years
|
|
Non-Sudden or Arrhythmic Causes of Mortality
기간: Median follow-up estimated to be 10.7 years
|
Competing causes of mortality in competing risk analyses. |
Median follow-up estimated to be 10.7 years
|
공동 작업자 및 조사자
협력자
수사관
- 수석 연구원: Christine M Albert, M.D., M.P.H., Brigham and Women's Hospital
간행물 및 유용한 링크
일반 간행물
- Silverman MG, Yeri A, Moorthy MV, Camacho Garcia F, Chatterjee NA, Glinge CSA, Tfelt-Hansen J, Salvador AM, Pico AR, Shah R, Albert CM, Das S. Circulating miRNAs and Risk of Sudden Death in Patients With Coronary Heart Disease. JACC Clin Electrophysiol. 2020 Jan;6(1):70-79. doi: 10.1016/j.jacep.2019.08.011. Epub 2019 Oct 30.
- Lee DC, Albert CM, Narula D, Kadish AH, Panicker GK, Wu E, Schaechter A, Pester J, Chatterjee NA, Cook NR, Goldberger JJ. Estimating Myocardial Infarction Size With a Simple Electrocardiographic Marker Score. J Am Heart Assoc. 2020 Feb 4;9(3):e014205. doi: 10.1161/JAHA.119.014205. Epub 2020 Jan 24.
- Chatterjee NA, Tikkanen JT, Panicker GK, Narula D, Lee DC, Kentta T, Junttila JM, Cook NR, Kadish A, Goldberger JJ, Huikuri HV, Albert CM; PREDETERMINE Investigators. Simple electrocardiographic measures improve sudden arrhythmic death prediction in coronary disease. Eur Heart J. 2020 Jun 1;41(21):1988-1999. doi: 10.1093/eurheartj/ehaa177.
- Panicker GK, Narula DD, Albert CM, Lee DC, Kothari S, Goldberger JJ, Cook N, Schaechter A, Kim E, Moorthy MV, Pester J, Chatterjee NA, Kadish AH, Karnad DR. Validation of electrocardiographic criteria for identifying left ventricular dysfunction in patients with previous myocardial infarction. Ann Noninvasive Electrocardiol. 2021 Mar;26(2):e12812. doi: 10.1111/anec.12812. Epub 2020 Oct 30.
- Venkateswaran RV, Moorthy MV, Chatterjee NA, Pester J, Kadish AH, Lee DC, Cook NR, Albert CM. Diabetes and Risk of Sudden Death in Coronary Artery Disease Patients Without Severe Systolic Dysfunction. JACC Clin Electrophysiol. 2021 Dec;7(12):1604-1614. doi: 10.1016/j.jacep.2021.05.014. Epub 2021 Jul 28.
- Adabag S, Patton KK, Buxton AE, Rector TS, Ensrud KE, Vakil K, Levy WC, Poole JE. Association of Implantable Cardioverter Defibrillators With Survival in Patients With and Without Improved Ejection Fraction: Secondary Analysis of the Sudden Cardiac Death in Heart Failure Trial. JAMA Cardiol. 2017 Jul 1;2(7):767-774. doi: 10.1001/jamacardio.2017.1413.
- Sandhu RK, Dron JS, Liu Y, Moorthy MV, Chatterjee NA, Ellinor PT, Chasman DI, Cook NR, Khera AV, Albert CM. Polygenic Risk Score Predicts Sudden Death in Patients With Coronary Disease and Preserved Systolic Function. J Am Coll Cardiol. 2022 Aug 30;80(9):873-883. doi: 10.1016/j.jacc.2022.05.049.
- Peek N, Hindricks G, Akbarov A, Tijssen JGP, Jenkins DA, Kapacee Z, Parkes LM, van der Geest RJ, Longato E, Sprague D, Taleb Y, Ong M, Miller CA, Shamloo AS, Albert C, Barthel P, Boveda S, Braunschweig F, Johansen JB, Cook N, de Chillou C, Elders P, Faxen J, Friede T, Fusini L, Gale CP, Jarkovsky J, Jouven X, Junttila J, Kautzner J, Kiviniemi A, Kutyifa V, Leclercq C, Lee DC, Leigh J, Lenarczyk R, Leyva F, Maeng M, Manca A, Marijon E, Marschall U, Merino JL, Mont L, Nielsen JC, Olsen T, Pester J, Pontone G, Roca I, Schmidt G, Schwartz PJ, Sticherling C, Suleiman M, Taborsky M, Tan HL, Tfelt-Hansen J, Thiele H, Tomaselli GF, Verstraelen T, Vinayagamoorthy M, Olesen KKW, Wilde A, Willems R, Wu KC, Zabel M, Martin GP, Dagres N. Sudden cardiac death after myocardial infarction: individual participant data from pooled cohorts. Eur Heart J. 2024 Nov 14;45(43):4616-4626. doi: 10.1093/eurheartj/ehae326.
- Chatterjee NA, Moorthy MV, Pester J, Schaecter A, Panicker GK, Narula D, Lee DC, Goldberger JJ, Kadish A, Cook NR, Albert CM; PRE-DETERMINE Study Group. Sudden Death in Patients With Coronary Heart Disease Without Severe Systolic Dysfunction. JAMA Cardiol. 2018 Jul 1;3(7):591-600. doi: 10.1001/jamacardio.2018.1049.
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
기본 완료 (추정된)
연구 완료 (추정된)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (추정된)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
추가 관련 MeSH 약관
기타 연구 ID 번호
- 2007P000840
- R01HL091069 (미국 NIH 보조금/계약)
- R01HL165840 (미국 NIH 보조금/계약)
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .